http://www.technologyreview.com/Biotech/19039/
Technology is quickly gathering tools to help in characterizing the cell surface antigens or the RF's (recognition factors) that play a central role in cancer.
We will create molecules that will "label" a cancer cell as producing certain CSA/RF's. Once we know where the cancer cell is in terms of it's present programming (remember, the existing CSA/RF is indicative of the particular cancer "stage"), we can present the cell with embryonic RF's that may alter the cell's behavior.
Technology is quickly gathering tools to help in characterizing the cell surface antigens or the RF's (recognition factors) that play a central role in cancer.
We will create molecules that will "label" a cancer cell as producing certain CSA/RF's. Once we know where the cancer cell is in terms of it's present programming (remember, the existing CSA/RF is indicative of the particular cancer "stage"), we can present the cell with embryonic RF's that may alter the cell's behavior.
Comments